World News

The deal also gives Ferring access to early-stage cell therapies and research models targeting other women’s health needs.

Under the agreement, Astellas will pay up to US$285 million in upfront and potential future option exercise payments, alongside up to US$1.05 billion in development and commercial milestones.

Talzenna (talazoparib), a PARP inhibitor, is used alongside Xtandi (enzalutamide), an androgen receptor inhibitor, to target cancer through complementary mechanisms.

The closure comes as Teva continues to restructure its business under its Pivot to Growth strategy, launched after Richard Francis became chief executive in 2023.

Abbott has integrated Oncodetect into electronic health record networks and is conducting more than 20 studies across multiple tumour types.

RadNet could also pay an additional earnout of up to US$210 million if ONRAD achieves specified earnings before interest, taxes, depreciation and amortisation (EBITDA) targets for 2027.

Freedom builds on the sensing technology used in Senseonics’ Eversense 365 CGM system.

The agreement extends the biotechnology company’s partnership with the Biomedical Advanced Research and Development Authority (BARDA), established in 2020.

The Board took note of the final report of its Working Group and approved the overall strategic direction for the transition.

Once expanded, the facility could have a total reactor volume exceeding 400 m³, increasing the company’s capacity to develop and manufacture active pharmaceutical ingredients (APIs).